Trubion Pharmaceuticals Inc. To Present At The JP Morgan 24th Annual Healthcare Conference

SEATTLE, Jan. 5 /PRNewswire/ -- Trubion Pharmaceuticals, Inc. today announced that it will present at the JP Morgan 24th Annual Healthcare Conference at 1:30 p.m. Pacific Time (4:30 p.m. EST) on Thursday, January 12, 2006 at the Westin St. Francis Hotel in San Francisco, California.

Peter Thompson, MD, FACP, President and Chief Executive Officer of Trubion, will provide an update on alliance development and progress in the company’s Small Modular Immunotherapeutics (SMIP(TM)) product programs.

About Trubion

Trubion Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat inflammatory disease and cancer. The company utilizes proprietary technology to develop drugs that are safer and more effective than currently available therapies. Trubion has multiple drug candidates in pre-clinical and clinical development. For additional information visit http://www.trubion.com .

Trubion Pharmaceuticals, Inc.

CONTACT: Peter Thompson, MD, FACP, of Trubion Pharmaceuticals, Inc.,+1-206-838-0500

MORE ON THIS TOPIC